A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men with Overactive Bladder (OAB) Symptoms on l Therapy for Benign Prostatic Hyperplasia (BPH)

Administered By

Awarded By

Contributors

Start/End

  • October 20, 2020 - November 30, 2023